Using Mounjaro with HRT: what you need to decide before starting

Why the type of HRT you take actually matters here

The concern isn't with HRT as a category, it's with oral HRT tablets specifically. Mounjaro activates both GIP and GLP-1 receptors, which among other effects slows the rate at which food and medicines move through the stomach. For most medicines this matters little, but for oral formulations that rely on being absorbed at a predictable rate through the gut wall, slower gastric emptying can reduce the amount that reaches your bloodstream.

Oral oestrogen tablets are in that group. If less oestrogen is absorbed than intended, you may not get the full effect of your HRT dose, something that could affect symptom control without being immediately obvious. NHS England's guidance for patients on weight-management injections explicitly flags this and recommends discussing a switch to transdermal HRT with your doctor. Transdermal preparations (patches, gels and sprays) deliver oestrogen directly through the skin, completely sidestepping the gut, so Mounjaro's effect on gastric emptying becomes irrelevant to their absorption.

Progestogen-only tablets and combined oral preparations sit in the same risk window as oral oestrogen. If you use a Mirena coil or a progestogen patch, those are unaffected. The picture varies depending on exactly what your HRT regimen looks like, which is why a prescriber needs to review it rather than you making the call alone. You can read more about the full clinical profile of tirzepatide on the tirzepatide overview page.

What the NHS guidance actually says, and what it doesn't

NHS England's advice is to consider transdermal HRT while on tirzepatide. That word matters. It isn't a blanket ban on oral HRT, and it doesn't mean oral HRT will definitely fail to work. It means the absorption risk is real enough that a prescriber should weigh it for your specific regimen and symptoms.

For women who are well-controlled on oral HRT and have been for years, a switch to patches or gel isn't always straightforward, some formulations aren't available transdermally, and individual responses to different preparations vary. So the guidance creates a conversation, not an automatic prescription change. What's not appropriate is continuing oral HRT alongside Mounjaro without ever raising the question with a clinician.

The NHS England page on weight-management injections covers this interaction alongside other practical considerations, surgery, contraception, and what to tell your healthcare team. It's worth a read if you're preparing for a consultation. For a broader look at treatment options and how a private prescription works, the weight-loss treatments page covers what to expect at each stage.

Making the decision: what a prescriber looks at

When a clinician reviews Mounjaro alongside HRT, they're balancing a few things at once. First, what your HRT regimen currently is: oral oestrogen only, combined oral, progestogen-only tablet, patch, gel, coil, or a combination. Second, how well your symptoms are controlled and whether any change to the HRT form would likely disrupt that. Third, whether a switch to transdermal is practical given what's available and what your GP has previously prescribed.

At nume (sorry, at our pharmacy) a named GPhC-registered prescriber reads every consultation personally. If you mention you're taking HRT (and you should, in the medical history section), the prescriber considers it as part of the clinical review, not as an afterthought. The interaction doesn't disqualify you from Mounjaro; it's a factor that shapes how your treatment is set up.

If you've been on Mounjaro for a while and only recently started HRT, or vice versa, it's equally worth flagging to both the prescriber managing your weight treatment and your GP. Keeping both clinicians informed is the safest route, and NHS England's guidance specifically recommends this kind of joined-up communication. If you want a full breakdown of the clinical considerations in one place, our page on whether you can take Mounjaro with HRT covers the interaction in detail. You can also explore how Mounjaro works in more detail if you're still weighing up whether it's right for your situation.

Storage, routine, and the practical side of running both treatments

A detail patients sometimes raise: the Mounjaro KwikPen lives in the fridge, and so do some HRT gel sachets or refrigerated progesterone preparations. Keeping a shared log of which medicines need cold storage can help avoid accidental mix-ups, particularly when travelling. If you're flying with Mounjaro, the same rules apply to any refrigerated HRT preparation you carry.

Beyond storage, running two treatments simultaneously means being clear with every clinician involved about the full list of what you take. That includes any over-the-counter supplements, thyroid medication, and the specific form your HRT takes. A prescriber who sees the complete picture is better placed to advise. The NHS patient information page for tirzepatide also covers medicines that may interact, and is worth reviewing alongside your Patient Information Leaflet. If you're curious about how other medicines interact with GLP-1 treatments more broadly, the GLP-1 interactions page covers the wider picture. You can find full prescribing and dosing information for the treatment itself on the Lily Mounjaro page.